- [ 2024-05-30 ] 2024년 제1차 사전연명의료의향서 등록기관 지정 결과 공고
- [ 2024-05-22 ] 2024년 한국생명윤리학회 춘계공동학술대회 개최 안내(6/28(금))
- [ 2024-05-22 ] 2024년 대한의료커뮤니케이션학회 춘계학술대회 개최 안내(6/8(토))
- [ 2024-05-10 ] 공용위원회 심의·협약 대상 및 비용 납부 안내 규정 공고
- [ 2024-05-07 ] 2024년 한국의료윤리학회 춘계학술대회 개최 안내(5/25(토))
| 발행년 : | 2015 |
|---|---|
| 구분 : | 국외학술지 |
| 학술지명 : | Nature Reviews Nephrology |
| 관련링크 : | http://www.riss.kr/link?id=O65649653 |
[자료 문의 : lib@nibp.kr / http://riss.kr 에서 직접 원문 복사 신청 가능, 관련링크 참고]
Long-term medical risks to the living kidney donor
제어번호 65649653
저자명 Lam, N. N. , Lentine, K. L. , Levey, A. S. , Kasiske, B. L. , Garg, A. X.
학술지명 NATURE REVIEWS NEPHROLOGY
권호사항 Vol.11 No.7 [2015]
발행처 Nature Publishing Group
자료유형 학술저널
수록면 411-419 [※수록면이 p5 이하이면, Review, Columns, Editor's Note, Abstract 등일 경우가 있습니다.]
ISSN 1759-5061
언어 eng
발행년도 2015년
http://www.riss.kr/link?id=O65649653
Living kidney donation benefits recipients and society but carries short-term and long-term risks for the donor. This Review summarizes the studies that underlie our current understanding of these risks in the first decade after donation, with a view to improving the informed consent process. Two studies report a higher risk of end-stage renal disease (ESRD) among donors than among healthy nondonors; however, the absolute 15-year incidence of ESRD is <1%. All-cause mortality and the risk of cardiovascular events are similar among donors and healthy nondonors, although one study provides evidence for a 5% increase in all-cause mortality after 25 years that is attributable to donation. Some evidence suggests that the 20-year incidence of gout is slightly higher among donors than among healthy nondonors. The risks of gestational hypertension or pre-eclampsia seem to be 6% higher in pregnancies among donors than in pregnancies among healthy nondonors. The incidences of acute kidney injury, kidney stones that require surgical intervention, gastrointestinal bleeding and fractures seem no higher among donors than among healthy nondonors, although some of these conclusions are based on a small number of events. Future studies must clarify the lifetime incidence of long-term outcomes, particularly in relation to a donor's age, race, and history of comorbidities.
Copyright (c)KONIBP All Right Reserved.
2sisstore
